Key facts
- Notable investors include Cowin Capital, IDG Capital, Mirae Asset Capital, YuanBio Venture Capital, Hillhouse Investment Group — 12 tracked in total.
- Status: In IPO Registration.
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for BrosMed
- ·The full record, as it builds
Funding rounds
No funding rounds for BrosMed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BrosMed
Developer and manufacturer of medical devices designed to improve procedural outcomes for physicians and surgeons. The company's devices consist of interventional cardiovascular catheter series and endovascular catheter series which is used by cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimally invasive devices, enabling clinicians to expand treatment options for the patient freedom and fulfilment at a lesser cost.
- Sector
- Healthcare
- HQ
- Dongguan, China
- Founded
- 2012
- Employees
- 170
- Website
- brosmed.com/
- Ownership
- In IPO Registration
BrosMed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BrosMed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BrosMed in its N-PORT filings yet. We sweep new filings monthly.